Limiting the use of drug-eluting stents to a selected group of patients saves money and do not increase death or heart attack risk, reveals analysis published in Circulation: Journal of the American Heart Association.
The selective use of drug-eluting stents, which began in 2007, is saving the U.S. healthcare system about $400 million annually, researchers said.
Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.